CONQUER CANCER

with the leader in precision oncology testing.

Precision oncology has the extraordinary power to improve patient outcomes at every stage of care.1 At Guardant Health, we’re unleashing that power through our revolutionary liquid and tissue tests.

Backed by over a decade of healthcare innovation.

Our testing solutions are built on more than 10 years of relentless research and

development—all with the purpose of expanding access to the best cancer care.

peer-reviewed

publications & research

abstracts

clinical outcomes

studies

ordering

oncologists

test results

delivered

lives covered

lifetime biopharma

customers

Transforming cancer care, together.

Select your path to see how.

Healthcare Providers

Explore our complete portfolio of tests and services that span the cancer care continuum.2-6

Patients

Learn how our tests can help you and your healthcare team create a personalized treatment plan.3-5

Biopharma Partners

Unlock the power of genomics and epigenomics to discover the next generation of therapies.7

References: 1. Rulten SL, Grose RP, Gatz SA, Jones JL, Cameron AJM. The future of precision oncology. Int J Mol Sci. 2023;24(16):12613. doi:10.3390/ijms241612613 2. Guardant Health data on file. October 19, 2023. Guardant Health, Inc. Redwood City, CA. 3. Guardant360® CDx Technical Information. Guardant Health, Inc. Redwood City, CA. February 2023. 4. Guardant360 TissueNextTM Assay Specifications. Guardant Health, Inc. Redwood City, CA. 5. Guardant360® Assay Specifications. October 14, 2024. Guardant Health, Inc. Redwood City, CA. 6. Guardant360 ResponseTM: Guide to Ordering Guardant360 Response. Guardant Health, Inc. Redwood City, CA. 7. Guardant Health data on file. April 1, 2024. Guardant Health, Inc. Redwood City, CA.